tert-Butyl 3-(1-methyl-1H-imidazol-2-yl)piperazine-1-carboxylate

Catalog No.: 
ACSHWK483
CAS No.: 
1702031-71-7
Molecular Formula: 
C13H22N4O2
Molecular Weight: 
266.35
tert-Butyl 3-(1-methyl-1H-imidazol-2-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$266.00InquiryInquiry
100mg98%$389.00InquiryInquiry
250mg98%$546.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(1-methyl-1H-imidazol-2-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 3-(1-methyl-1H-imidazol-2-yl)piperazine-1-carboxylate
MDL No.MFCD28383710
Molecular FormulaC13H22N4O2
Molecular Weight266.35
SMILESO=C(N1CC(C2=NC=CN2C)NCC1)OC(C)(C)C
InChI KeyQOYZRQSWXCLPIO-UHFFFAOYSA-N
Synonymtert-butyl 3-(1-methyl-1H-imidazol-2-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 3-(1-methyl-1H-imidazol-2-yl)-, 1,1-dimethylethyl ester
CAS No.1702031-71-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSHWK483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHWK483 route product structure diagram
    ACSHWK4831702031-71-7
Inquiry

2. ACSHWK483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHWK483 route product structure diagram
    ACSHWK4831702031-71-7
Inquiry

3. ACSHWK483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHWK483 route product structure diagram
    ACSHWK4831702031-71-7
Inquiry

Comments (0)